SEC Form 4 · accession 0000899243-15-002883
Aeon Global Health Corp. · AGHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J David Luce
Director
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $1.34 | Aug 7, 2015 | J | 1,119,403 | D | Sep 15, 2012 | Mar 15, 2017 | Common Stock | 1,119,403 | 0 | I |
| Warrant (right to buy) | $0.17 | Aug 7, 2015 | J | 1,119,403 | A | Aug 7, 2015 | Dec 13, 2019 | Common Stock | 1,119,403 | 1,119,403 | I |
| Warrant (right to buy) | $1.34 | Aug 7, 2015 | J | 1,550,387 | D | Mar 28, 2013 | Sep 28, 2017 | Common Stock | 1,550,387 | 0 | I |
| Warrant (right to buy) | $0.17 | Aug 7, 2015 | J | 1,550,387 | A | Aug 7, 2015 | Dec 13, 2019 | Common Stock | 1,550,387 | 1,550,387 | I |
| Warrant (right to buy) | $0.95 | Aug 7, 2015 | J | 2,450,000 | D | Dec 20, 2013 | Jun 20, 2018 | Common Stock | 2,450,000 | 0 | I |
| Warrant (right to buy) | $0.17 | Aug 7, 2015 | J | 2,450,000 | A | Aug 7, 2015 | Dec 13, 2019 | Common Stock | 2,450,000 | 2,450,000 | I |
| Warrant (right to buy) | $1.34 | Aug 7, 2015 | J | 155,039 | D | Mar 28, 2013 | Sep 28, 2017 | Common Stock | 155,039 | 0 | I |
| Warrant (right to buy) | $0.17 | Aug 7, 2015 | J | 155,039 | A | Aug 7, 2015 | Dec 13, 2019 | Common Stock | 155,039 | 155,039 | I |
| Warrant (right to buy) | $0.95 | Aug 7, 2015 | J | 200,000 | D | Dec 20, 2013 | Jun 20, 2018 | Common Stock | 200,000 | 0 | I |
| Warrant (right to buy) | $0.17 | Aug 7, 2015 | J | 200,000 | A | Aug 7, 2015 | Dec 13, 2019 | Common Stock | 200,000 | 200,000 | I |
Explanation of responses
- F1The reported transactions involve an amendment of the warrants to amend the exercise price and expiration date, resulting in the deemed cancellation of the old warrants and the simultaneous issuance of new warrants for purposes of Section 16.